Adapting to Immuno-Oncology’s R&D Challenges: Refocusing on Innate Immunity as a “Next Big Thing” in Cancer Immunotherapy

Dr. Borriello was a featured speaker at a live webinar entitled “Adapting to Immuno-Oncology’s R&D Challenges: Refocusing on Innate Immunity as the ‘Next Big Thing’ in Cancer Immunotherapy”. The live webinar, moderated by Lumanity, brought together a diverse array of biotech companies with a range of platforms and modalities to modulate innate pathways, with the goal of…